Researchers identify pivotal immune cell in Type 1 diabetes in humans

January 12, 2012 in Immunology

(Medical Xpress) -- Researchers at the La Jolla Institute for Allergy & Immunology have proven – for the first time in human tissues -- the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and provides a key focal point for interrupting the disease process.

"This study marks the first time that the presence of beta cell-reactive T cells has been directly proven in pancreas tissues from type 1 diabetes patients," explained Ken Coppieters, Ph.D., first author on the study published online January 2nd in the in the Journal of Experimental Medicine. "Previously, it was only known in plastic dishes or mouse models. What is unique about this study is the use of human tissue."

Human pancreatic tissue for the studies was provided through a collaborative type 1 diabetes research consortium funded by JDRF, a leading charitable supporter of type 1 diabetes research. The JDRF's Network for Pancreatic Organ Donors with Diabetes (nPOD) provides rare and difficult to obtain pancreatic tissues to carefully selected research organizations worldwide. Participating institutions are chosen based on their history and quality of type 1 diabetes research.

"Mice represent an excellent model for disease, but eventually it is important to confirm in human tissues the things that you learn in mice," said Matthias von Herrath, M.D., a world- renowned type 1 diabetes researcher, who led the scientific team. "The use of this tissue from the nPOD consortium was critical to our ability to prove which T cells are most important in destroying beta cells in humans, which leads to type 1 diabetes, and where these cells are located in the pancreas." The study was published in a paper entitled, "Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients." Dr. von Herrath was senior author.

Previously, the research community had assumed, based on lab and mouse studies, that T cells – the body's soldier-like attack cells -- recognize and react against certain molecular structures on the beta cells and then kill the beta cells. The La Jolla Institute study confirmed this occurrence and showed the T cells location in the islets of the pancreas, which house the beta cells. The team is also is the first to identify the specific T cells -- CD8 -- as being key in the destruction of beta cells. This destruction eventually leads to the beta cell's inability to produce insulin, the hallmark of type 1 diabetes.

Dr. Coppieters, formerly of the La Jolla Institute and now at Ghent University, Belgium, said the study serves to clarify an important step in the type 1 diabetes process in humans. "It points to the CD8 T cells as being one of the most important cells that we should focus on to stop type 1 diabetes progression, once it is already underway."

In addition, the research team identified the places on the that trigger the T cell attack. T cells come in several different types and, in type 1 diabetes, react against a variety of substances produced within the body.

"Knowing which pieces of the molecules the T cells react against is a crucial prerequisite to design therapies that attempt to restore balance within the immune system," said Dr. Coppieters.

Teodora Staeva, Ph.D., director of JDRF's Immune Therapies Program, called the paper "very important" for the diabetes field. "We are certainly very pleased that nPOD enabled this study through the supply of human tissue," she said. "It is a perfect example of the kind of cutting-edge research that JDRF is proud to support to catalyze major research advances in type 1 ."

She said the findings are the latest of several important papers resulting from collaborations between researchers around the world and nPOD, since the project was launched in 2007. nPOD currently supports over 70 1 diabetes-related scientific studies at various institutions.

Journal reference: Journal of Experimental Medicine search and more info website

Provided by La Jolla Institute for Allergy and Immunology

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Stem-cell-based strategy boosts immune system in mice

Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, ...

Immunology created May 16, 2013 | popularity 4.8 / 5 (5) | comments 0 | with audio podcast

Resistance to visceral leishmaniasis: New mechanisms involved

Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 ...

Immunology created May 16, 2013 | popularity not rated yet | comments 0

Women's immune systems remain younger for longer

Women's immune systems age more slowly than men's, suggests research in BioMed Central's open access journal Immunity & Ageing. The slower decline in a woman's immune system may contribute to women living longer than men. ...

Immunology created May 14, 2013 | popularity not rated yet | comments 0

Newly described type of immune cell and T cells share similar path to maturity, according to new study

(Medical Xpress)—Labs around the world, and a core group at Penn, have been studying recently described populations of immune cells called innate lymphoid cells (ILCs). Some researchers liken them to foot soldiers that ...

Immunology created May 14, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Not all cytokine-producing cells start out the same way, study finds

(Medical Xpress)—Cytokines are molecules produced by immune cells that induce the migration of other cells to sites of infection or injury, promote the production of anti-microbial agents, and signal the production of inflammatory ...

Immunology created May 13, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Individuals who drink heavily and smoke may show 'early aging' of the brain

Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic. Multiple factors can influence both the type and degree of neurocognitive abnormalities ...